Signia Announces U.S. Availability of Insio Charge&Go CIC IX Hearing Aid
The rechargeable completely-in-canal device features binaural one-mic directional technology designed to improve speech understanding in noise.
The rechargeable completely-in-canal device features binaural one-mic directional technology designed to improve speech understanding in noise.
Hearing loss frustrations were relieved through Signia’s Styletto hearing aids, which can process speech and background noise separately.
Developed in partnership with WS Audiology (“WSA”), Sony will “enhance the lives of consumers by combining its unique premium technology, ultimate ease of use, and uncompromised comfort and wearability, to deliver an unprecedented hearing experience that easily bridges the gap between the wearer and their environment.”
Mergers and acquisitions came back strong in 2021 after the pandemic, and M&As have started strong in 2022.
Read MoreAn article in MedWatch today notes the disruptions in trading created by Russia’s invasion of Ukraine. Here are some quotes from hearing aid manufacturers and their chief executives on the situation.
Read MoreThe Group’s performance in Q1 was fueled by sales growth in both wholesale and consumer facing businesses in all regions, the company reports.
Read MoreWiinholt will join WS Audiology from Ørsted, Denmark’s “largest and the world’s most sustainable energy company” where she has been CFO since 2013 and acted as Senior Vice President, Corporate Finance since 2004. Prior to that she worked in senior roles at Borealis and Arthur Andersen.
Read MoreWSA grew revenue organically by 22% to pass the EUR 2 billion mark (USD $2.3 billion) and simultaneously delivered a historically strong normalized EBITDA of EUR 464 million (USD $524 million) – an increase of 40% compared to the year before, according to the announcement.
Read MoreWS Audiology announced that its Group CFO Søren Westh Lonning will step down on November 8, 2021, to fully focus on recovering from back pain issues. Michael Tyroller will assume the position as interim Group CFO from the same date after previously having acted as interim Group CFO of WS Audiology from June 1 until October 31, 2020.
Read MoreNeuromod Devices Ltd, the medical device company which specializes in neuromodulation technologies, has announced the appointment of Eric Timm as Chief Executive Officer of its recently established US entity, Neuromod USA Inc, effective from October 1, 2021.
Read MoreThe 2021 Edition of the Map is the latest in a longstanding series of diagrams that illuminates the hidden connections between hearing aid manufacturers and their subsidiaries.
Read MoreNeuromod Devices Ltd, the Irish medical device company specializing in the treatment of tinnitus, has announced the establishment of Neuromod USA Inc, headquartered in Oak Brook, Ill. Three executives with significant experience in the hearing health industry have been appointed to the Neuromod USA leadership team as the organization prepares to enter the US market with its medical device for tinnitus treatment, pending approval from the Food and Drug Administration (FDA).
Read MoreWS Audiology announced the results of its latest financial report, indicating that it generated “strong revenue and earnings growth in Q3 of the fiscal year 2020/21 (April 1– June 30, 2021) compared to 2019/20,” which was significantly impacted by COVID-19.
Read MoreHeadquartered in Sandy, Utah, MHC reportedly has about 100 offices in the western United States (CO, ID, MT, NV, OR, UT, WA, WY, AR). The My Hearing Centers brand and operations have 166 employees, with an annual revenue of more than $30 million.
Read MoreThe companies all commit to the science-based targets initiative, or SBTi, according to the announcement. SBTi is a partnership between Carbon Disclosure Project (CDP), the United Nations Global Compact, World Resources Institute (WRI), and the World Wildlife Fund for Nature (WWF).
Read MoreWS Audiology announced that the company generated what it reports as strong revenue and earnings growth in the first half (H1) of its fiscal year (October 2020 through March 2021) in the face of the COVID-19 pandemic. According to its announcement, WS Audiology has continued to bring innovative products to market and has “upgraded the full-year revenue and profitability outlook.”
Read MoreSignia Active Pro are “specifically tailored to each individual wearer, whereas basic hearables boost all sound.” The company says “that can mean the difference between treating mild hearing loss effectively and developing more serious hearing loss.”
Read MoreWS Audiology announced its ranking as the “top patent applicant for conventional hearing assistive technology,” according to the 2021 World Intellectual Property Organization (WIPO) report.
Read More